Dr. David Rabuka is a serial biotech entrepreneur and investor based in Berkeley California. His expertise is concentrated on translating new technologies into clinical therapies. In 2024, Dr. Rabuka spoke about investment trends & opportunities in life sciences and biotech at our Annual General Meeting. Check out our shortened & lightly edited transcript.
Read MoreMeet Dr. Molly Gibson – Co-Founder and Chief Strategy & Innovation Officer at Generate:Biomedicines, Origination Partner at Flagship Pioneering. LDV Capital's Founder & General Partner Evan Nisselson discussed with Molly how AI and machine learning empower and disrupt the scientific process across life sciences, biotech, advanced materials and more.
If you missed our 10th Annual LDV Vision Summit, this is your chance to watch the video or read our shortened & lightly edited transcript.
Read MoreAs the biotech industry heavily relies on data filtering, analysis, and sharing, visual technologies play a critical role in detecting and imaging biological systems. This paves the way for the future of life sciences tools, enabling next-generation therapeutics, biomanufacturing, and longevity. At our 10th Annual LDV Vision Summit earlier this year, a panel of experts delved into these topics and explored various critical aspects shaping the future of biotechnology. Check out their insights.
Read MoreIn the lead-up to our 8th Annual LDV Vision Summit, Evan Nisselson had the privilege of chatting with Amy Kruse, General Partner of Prime Movers Lab. On March 23rd, she will take part in our panel discussion on investing trends in businesses powered by visual technologies.
Read More
